Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study

Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study

Huan Gao,1 Tao Tian,1 Suoni Li,2 Yinbin Zhang,3 Xiao Fu,1 Xiaoqiang Zheng,1 Na Liu,1 Aimin Jiang,1 Mengdi Ren,1 Xiaoni Zhang,1 Xuan Liang,1 Zhiping Ruan,1 Zhimin Geng,4,* Yu Yao1,* 1Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an,...

Full description

Bibliographic Details
Main Authors:	Gao H, Tian T, Li S, Zhang Y, Fu X, Zheng X, Liu N, Jiang A, Ren M, Zhang X, Liang X, Ruan Z, Geng Z, Yao Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-01-01
Series:	Cancer Management and Research
Subjects:	biliary tract cancer adjuvant chemotherapy gemcitabine platinum s-1
Online Access:	https://www.dovepress.com/efficacy-analysis-of-adjuvant-chemotherapy-with-gemcitabine-plus-plati-peer-reviewed-article-CMAR

Similar Items

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
by: Alexander R. Siebenhüner, et al.
Published: (2018-01-01)

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study
by: Kazuhito Mita, et al.
Published: (2010-12-01)

Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
by: Xiuqiong Chen, et al.
Published: (2021-03-01)

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
by: Hyera Kim, et al.
Published: (2020-01-01)

A meta-analysis of Pemetrexed plus Platinum Chemotherapy versus Gemcitabine plus Platinum Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Jin JIANG, et al.
Published: (2011-01-01)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
by: Chiao-En Wu, et al.
Published: (2020-10-01)

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
by: Chiao-En Wu, et al.
Published: (2021-06-01)

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
by: Chiao-En Wu, et al.
Published: (2020-05-01)

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
by: Hanna Lagenfelt, et al.
Published: (2021-07-01)

Adjuvant treatment after resection of biliary-tract cancer: yes or no?
by: Eveline Boucher, et al.
Published: (2011-12-01)

Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines
by: Yasunari Sakamoto, et al.
Published: (2019-09-01)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
by: Xiaobo Bo, et al.
Published: (2018-03-01)

The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
by: Young Saing Kim, et al.
Published: (2017-01-01)

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
by: Yoichi Miyata, et al.
Published: (2021-03-01)

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study
by: Sung-Nan Pei, et al.
Published: (2021-07-01)

Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
by: Masashi Tsunematsu, et al.
Published: (2019-06-01)

Gemcitabine plus platinum versus docetaxel plus platinum as first line therapy for metastatic nasopharyngeal carcinoma: A randomized clinical study
by: Hui Yang, et al.
Published: (2021-01-01)

Presentation and Outcomes with First-Line Chemotherapy in Advanced Cholangiocarcinomas—A Relatively Rare Component of Biliary Tract Cancers in India
by: Prabhat G. Bhargava, et al.
Published: (2020-10-01)

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study
by: Shinogu Takashima, et al.
Published: (2020-10-01)

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
by: Shoji Nagao, et al.
Published: (2020-02-01)

A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy
by: Makoto Ueno, et al.
Published: (2021-03-01)

Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer
by: Vanita Noronha, et al.
Published: (2012-01-01)

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
by: Yi-Ru Pan, et al.
Published: (2020-11-01)

Essential updates to the surgical treatment of biliary tract cancer
by: Satoshi Matsukuma, et al.
Published: (2019-07-01)

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
by: Osamu Itano, et al.
Published: (2020-07-01)

A meta Analysis of Gemcitabine plus Platinum Chemotherapy Compared with Single-agent Chemotherapy in the Treatment of Non-small Cell Lung Cancer
by: Lei JIANG, et al.
Published: (2010-03-01)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
by: Florian Moik, et al.
Published: (2020-09-01)

Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis
by: Cao, Y., et al.
Published: (2022)

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer
by: Zhu X, et al.
Published: (2018-10-01)

The Combination of Icotinib Hydrochloride and Fluzoparib Enhances the Radiosensitivity of Biliary Tract Cancer Cells
by: Zhu L, et al.
Published: (2020-11-01)

Biliary tract cancer: current challenges and future prospects
by: Ghidini M, et al.
Published: (2018-12-01)

Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
by: Hyehyun Jeong, et al.
Published: (2021-01-01)

Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
by: Zong Y, et al.
Published: (2020-12-01)

Chemotherapy for Biliary Tract Cancer in 2021
by: Takashi Sasaki, et al.
Published: (2021-07-01)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
by: Chen, Q., et al.
Published: (2022)

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
by: Changhoon Yoo, et al.
Published: (2021-04-01)

A nomogram to predict overall survival for biliary tract cancer
by: Song W, et al.
Published: (2018-06-01)

Clinical Advances in the Diagnosis and Treatment of Biliary Tract Diseases
Published: (2023)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study
by: Go, S.-I, et al.
Published: (2022)